The risk of prostate cancer was 24% higher among 9/11 rescue and recovery workers after the attacks on the World Trade Center in 2001, with the highest risk among the earliest responders, finds research published online in the journal Occupational & Environmental Medicine. The findings indicate a shorter latency period […]
Consumption of ultra-processed foods and drink could increase the risk of developing colorectal cancer. This was the conclusion of a large study undertaken by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, based on questionnaires about food behaviors completed by around 8,000 people […]
One in six men being treated for advanced prostate cancer experiences a reduced sense of smell and taste, a symptom that could cause increased anxiety among patients because it is also a side effect of COVID-19, according to Tulane researchers. A study published in the journal Supportive Care in Cancer […]
A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 patients. The findings appear in the March issue […]
Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday. As opposed to currently approved hormone therapies that are injected or placed as implants under the skin, Orgovyx is administered orally […]
Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime. When diagnosed, a patient’s disease is graded from 1 to 5 based on how aggressive it is, with 5 being the most aggressive. Those with […]
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of “financial toxicity,” reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. The cost of cancer care can be […]
A depression pill from 70 years ago could be used to treat prostate cancer, research suggests An antidepressant from the Fifties could treat prostate cancer and reduce side-effects of other treatments. Results of a small trial suggest that the drug phenelzine, which treats depression (by altering levels of brain chemicals […]
One of the thorniest dilemmas posed by prostate cancer is whether, and when, to give radiation therapy—with its potential bad side effects—to men after surgery to remove the prostate gland. Now, three new randomized clinical trials—the gold-standard type of study—and a statistical “meta-analysis” of their results conclude that routinely giving […]